v3.26.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 2,547 $ 4,139
Trade accounts receivable, less allowance for credit losses of $90 and $80, respectively 10,833 11,108
Prepaid expenses 5,662 3,914
Income taxes receivable 481 528
Other current assets 461 520
Total current assets 19,984 20,209
Net property and equipment 40,305 40,474
Intangible assets, net 2,165 2,227
Goodwill 66,152 66,152
Deferred contract costs, net 3,123 2,498
Other noncurrent assets 2,830 3,318
Total assets 134,559 134,878
Current liabilities:    
Current portion of notes payable, net of unamortized debt issuance costs 4,015 4,014
Accounts payable 2,227 1,169
Accrued wages and bonuses 6,603 7,218
Accrued expenses 2,582 2,897
Dividends payable 3,606 3,625
Deferred revenue 17,192 16,201
Income Taxes Payable 1,768 550
Other current liabilities 477 946
Total current liabilities 38,470 36,620
Notes payable, net of current portion and unamortized debt issuance costs 74,017 75,021
Deferred income taxes 5,999 5,984
Other long-term liabilities 2,578 3,263
Total liabilities 121,064 120,888
Shareholders’ equity:    
Preferred stock, $0.01 par value, authorized 2,000,000 shares, none issued 0 0
Common stock, $0.001 par value; authorized 110,000,000 shares, issued 31,966,504 in 2025 and 31,072,144 in 2024, outstanding 22,637,252 in 2025 and 23,083,116 in 2024 32 32
Additional paid-in capital 185,627 183,880
Accumulated deficit (17,682) (17,298)
Treasury stock, 9,329,252 and 7,989,028 Common shares in 2025 and 2024, respectively, at cost (154,482) (152,624)
Total shareholders’ equity 13,495 13,990
Total liabilities and shareholders’ equity $ 134,559 $ 134,878